CAS 19891-51-1
:(1S,2R,3aS,5aS,6R,10bS,10cR)-1,2,6-trihydroxy-3a,10b-dimethyl-7-(1-methylethyl)-1,2,3,3a,5a,6,10b,10c-octahydro-4H,9H-[2]benzofuro[7,1-fg]isochromene-4,9-dione
Description:
The chemical substance with the name "(1S,2R,3aS,5aS,6R,10bS,10cR)-1,2,6-trihydroxy-3a,10b-dimethyl-7-(1-methylethyl)-1,2,3,3a,5a,6,10b,10c-octahydro-4H,9H-[2]benzofuro[7,1-fg]isochromene-4,9-dione" and CAS number "19891-51-1" is a complex organic compound characterized by its multi-ring structure, which includes a benzofuro and isochromene moiety. This compound features multiple hydroxyl groups, indicating it has significant potential for hydrogen bonding, which can influence its solubility and reactivity. The presence of chiral centers suggests that it may exist in multiple stereoisomeric forms, which can affect its biological activity and interactions. The dimethyl and isopropyl substituents contribute to its hydrophobic character, potentially impacting its pharmacokinetics if it has biological relevance. Overall, this compound's intricate structure and functional groups suggest it may have applications in medicinal chemistry or as a natural product, although specific biological activities would require further investigation.
Formula:C19H24O7
InChI:InChI=1/C19H24O7/c1-7(2)13-11-8(5-10(21)25-13)19(4)15-14(12(11)22)26-17(24)18(15,3)6-9(20)16(19)23/h5,7,9,12,14-16,20,22-23H,6H2,1-4H3/t9-,12-,14-,15+,16-,18+,19-/m1/s1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
(1S)-1,2,3,3a,5aβ,6,10b,10cβ-Octahydro-1,2α,6α-trihydroxy-3aβ,10bα-dimethyl-7-isopropyl-4H,9H-furo[2',3',4'
CAS:Formula:C19H24O7Purity:98.0%Molecular weight:364.3897Nagilactone B
CAS:<p>Nagilactone B is extracted from the root bark of Podocarpus nagi and it also is a liver X receptor (LXR) agonist.</p>Formula:C19H24O7Purity:98%Color and Shape:SolidMolecular weight:364.39Nagilactone B
CAS:<p>Nagilactone B is a molecule that belongs to the class of natural products. It exhibits an inhibitory effect on the uptake of cholesterol in cells and has been shown to reduce levels of low-density lipoprotein (LDL) cholesterol. Nagilactone B inhibits ATP binding cassette transporter A1 (ABCA1), which is involved in the cellular uptake of cholesterol. The molecule also inhibits messenger RNA (mRNA) expression for apolipoprotein A1 (APOA1) and liver receptor homolog-1 (LRH-1). Nagilactone B has been found to have anticancer activity in animal models and may be a potential treatment for cancer. This drug has also been shown to lower serum lipid levels, which could be beneficial for patients with hypercholesterolemia and other lipid disorders.</p>Formula:C19H24O7Purity:Min. 95%Molecular weight:364.4 g/mol



